Fluoroquinolones compared to 1% azithromycin in DuraSite® for bacterial conjunctivitis [from Lichenstein and Granet] and Response to correspondence [from Friedlaender and Protzko] ||FREE PAPER||
Steven J Lichtenstein1, David B Granet21Associate Clinical Professor of Pediatrics and Surgery, University of Illinois College of Medicine at Peoria and Chicago, Peoria, IL, USA, 2Anne F. Ratner Professor of Ophthalmology and Pediatrics, University of California at San Diego, San Diego, CA, USAIn a...
Guardado en:
Autores principales: | Steven J Lichtenstein, David B Granet, Mitchell H Friedlaender, Eugene Protzko |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2008
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f4cbf53cb767490792377a133e598c27 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Azithromycin in DuraSite® for the treatment of blepharitis
por: Jodi Luchs
Publicado: (2010) -
Kinetics of kill of bacterial conjunctivitis isolates with moxifloxacin, a fluoroquinolone, compared with the aminoglycosides tobramycin and gentamicin
por: Rudolph S Wagner, et al.
Publicado: (2010) -
Ocular pharmacokinetics of bimatoprost formulated in DuraSite compared to bimatoprost 0.03% ophthalmic solution in pigmented rabbit eyes
por: Shafiee A, et al.
Publicado: (2013) -
A 3-day regimen with azithromycin 1.5% eyedrops for the treatment of purulent bacterial conjunctivitis in children: efficacy on clinical signs and impact on the burden of illness
por: Bremond-Gignac D, et al.
Publicado: (2015) -
Contabilidad en moneda dura
por: Carrasco P., Eduardo, et al.
Publicado: (1999)